Anti-angiogenic trials; key highlights of the 14th WCGC
Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium
Anti-angiogenic trials; key highlights of the 14th WCGC ( Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium )
17 Jul 2012
Epigenetics of cancer and changes in DNA modification in tumours
Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours  ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain   )
16 Jul 2012
Perifosine disappoints in refractory mCRC
Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
Perifosine disappoints in refractory mCRC ( Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA )
16 Jul 2012
Screening and specialist nurses central to patient care
Jola Gore-Booth – EuropaColon, France / UK
Screening and specialist nurses central to patient care ( Jola Gore-Booth – EuropaColon, France / UK )
16 Jul 2012
Tivantinib first drug to have overall survival benefit as second-line hepatocell...
Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia,...
Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment ( Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy )
16 Jul 2012
Adjuvant cetuximab disappoints again in mCRC
Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC ( Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France )
16 Jul 2012
Young Voices United against CRC
Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia
Young Voices United against CRC ( Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia )
16 Jul 2012
Advances in radiotherapy for rectal cancer
Dr Karin Haustermans – University Hospital Leuven, Belgium
Advances in radiotherapy for rectal cancer  ( Dr Karin Haustermans – University Hospital Leuven, Belgium )
16 Jul 2012
Important to support young medical oncologists’ research
Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy
Important to support young medical oncologists’ research  ( Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy )
16 Jul 2012
Role of family history and genetic testing in diagnosis
Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis  ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012
Effects of panitumumab against oesophageal-gastro cancer and carcinomas
Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK
Effects of panitumumab against oesophageal-gastro cancer and carcinomas ( Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK )
15 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved targ...
Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George	 Demetri - Dana-Farber Cancer Institute, Boston, USA )
13 Jun 2012